ProCE Banner Activity

GEMS: ART Resistance in Persons Diagnosed With HIV After PrEP Rollout in Sub-Saharan Africa

Slideset Download
Conference Coverage
While the number of PrEP breakthrough infections was small, there was a high frequency of ART resistance in HIV-infected persons on TDF-based PrEP in Kenya, Zimbabwe, Eswatini, and South Africa.

Released: July 24, 2021

Expiration: July 23, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner